Fluorosalan
Fluorosalan is an NF-κB inhibitor. Fluorosalan blocks the NF-κB signaling pathway by inhibiting the phosphorylation of IκBα. Fluorosalan induces depolarization of mitochondrial membrane potential in cancer cells and inhibits the growth of various cancer cells. Fluorosalan can be used in studies related to cervical cancer and rheumatoid arthritis.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 4776-06-1
- Fòrmula: C14H8Br2F3NO2
- Peso molecular:439.03
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| ME-180 | IC50 |
9.0 μM
|
Inhibition of cell viability in ME180 human cervical cancer cells assessed by CellTiter-Glo ATP quantitation assay after 24 h incubation.
Inhibition of cell viability in ME180 human cervical cancer cells assessed by CellTiter-Glo ATP quantitation assay after 24 h incubation.
|
20067776 |
| ME-180 | IC50 |
2.7 μM
|
Inhibition of cell viability in ME180 human cervical cancer cells assessed by CellTiter-Glo ATP quantitation assay after 48 h incubation.
Inhibition of cell viability in ME180 human cervical cancer cells assessed by CellTiter-Glo ATP quantitation assay after 48 h incubation.
|
20067776 |
| ME-180 | IC50 |
1.3 μM
|
Inhibition of cell viability in ME180 human cervical cancer cells assessed by CellTiter-Glo ATP quantitation assay after 72 h incubation.
Inhibition of cell viability in ME180 human cervical cancer cells assessed by CellTiter-Glo ATP quantitation assay after 72 h incubation.
|
20067776 |
| HeLa | IC50 |
3.1 μM
|
Inhibition of cell viability in HeLa human cervical cancer cells assessed by CellTiter-Glo ATP quantitation assay after 24 h incubation.
Inhibition of cell viability in HeLa human cervical cancer cells assessed by CellTiter-Glo ATP quantitation assay after 24 h incubation.
|
20067776 |
| HeLa | IC50 |
2.1 μM
|
Inhibition of cell viability in HeLa human cervical cancer cells assessed by CellTiter-Glo ATP quantitation assay after 48 h incubation.
Inhibition of cell viability in HeLa human cervical cancer cells assessed by CellTiter-Glo ATP quantitation assay after 48 h incubation.
|
20067776 |
| HeLa | IC50 |
3.3 μM
|
Inhibition of cell viability in HeLa human cervical cancer cells assessed by CellTiter-Glo ATP quantitation assay after 72 h incubation.
Inhibition of cell viability in HeLa human cervical cancer cells assessed by CellTiter-Glo ATP quantitation assay after 72 h incubation.
|
20067776 |
In Vitro
Fluorosalan (30 min) inhibits TNF-α-induced phosphorylation of IκBα at serine-32 in GFP-IκBα GripTite HEK293 cells, with an IC50 of 2.8 μM[1].
Fluorosalan (10 μM; 1 h) reduces TNF-α-induced phosphorylation of IκBα at serine-32 in IkB HEK293 cells[1].
Fluorosalan (5-72 h) inhibits the viability of human cervical cancer HeLa cells, with IC50 values of 3.1 μM (24 h), 2.1 μM (48 h) and 3.3 μM (72 h)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:IkB HEK293 cells
-
Concentration:10 μM
-
Incubation Time:1 h
-
Result:Reduced TNF-α-induced IκBα phosphorylation at serine-32.
- Kinase activity and phosphorylation assays
- Western Blot
- Collagen-Induced Arthritis
- Mitochondrial membrane-potential fluorescent assay
- Fluorescent plasma-membrane potential dye assay
- Mitochondrial membrane-potential and mitochondrial mass staining
- Research Protocol for Inflammation-related Diseases
- Protocol for Kinase activity and phosphorylation assays
Chemical Information
-
No. CAS 4776-06-1
-
Peso molecular 439.03
-
Fòrmula C14H8Br2F3NO2
-
SMILES
O=C(NC1=CC=CC(=C1)C(F)(F)F)C=2C=C(Br)C=C(Br)C2O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)